174 related articles for article (PubMed ID: 37147783)
21. Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration.
Son S; Deepagan VG; Shin S; Ko H; Min J; Um W; Jeon J; Kwon S; Lee ES; Suh M; Lee DS; Park JH
Acta Biomater; 2018 Oct; 79():294-305. PubMed ID: 30134209
[TBL] [Abstract][Full Text] [Related]
22. Dextran-doxorubicin prodrug nanoparticles conjugated with CD147 monoclonal antibody for targeted drug delivery in hepatoma therapy.
Tian H; Yu L; Zhang M; He J; Sun X; Ni P
Colloids Surf B Biointerfaces; 2023 Aug; 228():113400. PubMed ID: 37331192
[TBL] [Abstract][Full Text] [Related]
23. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.
Chen Y; Yao Z; Liu P; Hu Q; Huang Y; Ping L; Zhang F; Tang H; Wan T; Ping Y; Li B
Acta Biomater; 2023 Mar; 159():275-288. PubMed ID: 36709836
[TBL] [Abstract][Full Text] [Related]
24. Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.
Fan Y; Li M; Ma K; Hu Y; Jing J; Shi Y; Li E; Dong D
Cancer Biol Ther; 2019; 20(5):617-632. PubMed ID: 30462562
[TBL] [Abstract][Full Text] [Related]
25. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
[TBL] [Abstract][Full Text] [Related]
26. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
Xiong S; Wang Z; Liu J; Deng X; Xiong R; Cao X; Xie Z; Lei X; Chen Y; Tang G
Colloids Surf B Biointerfaces; 2019 Jan; 173():346-355. PubMed ID: 30316081
[TBL] [Abstract][Full Text] [Related]
27. Zwitterionic shielded polymeric prodrug with folate-targeting and pH responsiveness for drug delivery.
Li L; Song Y; He J; Zhang M; Liu J; Ni P
J Mater Chem B; 2019 Feb; 7(5):786-795. PubMed ID: 32254853
[TBL] [Abstract][Full Text] [Related]
28. Hydroxyethyl starch-folic acid conjugates stabilized theranostic nanoparticles for cancer therapy.
Wang C; Wang Q; Wang H; Li Z; Chen J; Zhang Z; Zeng H; Yu X; Yang X; Yang X; Li Z
J Control Release; 2023 Jan; 353():391-410. PubMed ID: 36473606
[TBL] [Abstract][Full Text] [Related]
29. Stimuli-responsive polymeric prodrug-based nanomedicine delivering nifuroxazide and doxorubicin against primary breast cancer and pulmonary metastasis.
Luo L; Xu F; Peng H; Luo Y; Tian X; Battaglia G; Zhang H; Gong Q; Gu Z; Luo K
J Control Release; 2020 Feb; 318():124-135. PubMed ID: 31838206
[TBL] [Abstract][Full Text] [Related]
30. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy.
Yin T; Wang Y; Chu X; Fu Y; Wang L; Zhou J; Tang X; Liu J; Huo M
ACS Appl Mater Interfaces; 2018 Oct; 10(42):35693-35704. PubMed ID: 30259743
[TBL] [Abstract][Full Text] [Related]
31. Codelivered Chemotherapeutic Doxorubicin
Lan Y; Liang Q; Sun Y; Cao A; Liu L; Yu S; Zhou L; Liu J; Zhu R; Liu Y
ACS Appl Mater Interfaces; 2020 Jul; 12(28):31904-31921. PubMed ID: 32551517
[TBL] [Abstract][Full Text] [Related]
32. PhAc-ALGP-Dox, a Novel Anticancer Prodrug with Targeted Activation and Improved Therapeutic Index.
Casazza A; Van Helleputte L; Van Renterghem B; Pokreisz P; De Geest N; De Petrini M; Janssens T; Pellens M; Diricx M; Riera-Domingo C; Wozniak A; Mazzone M; Schöffski P; Defert O; Reyns G; Kindt N
Mol Cancer Ther; 2022 Apr; 21(4):568-581. PubMed ID: 35149549
[TBL] [Abstract][Full Text] [Related]
33. ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer.
Yi H; Lu W; Liu F; Zhang G; Xie F; Liu W; Wang L; Zhou W; Cheng Z
J Nanobiotechnology; 2021 May; 19(1):134. PubMed ID: 33975609
[TBL] [Abstract][Full Text] [Related]
34. Low density lipoprotein-inspired nanostructured lipid nanoparticles containing pro-doxorubicin to enhance tumor-targeted therapeutic efficiency.
Li W; Fu J; Ding Y; Liu D; Jia N; Chen D; Hu H
Acta Biomater; 2019 Sep; 96():456-467. PubMed ID: 31260821
[TBL] [Abstract][Full Text] [Related]
35.
Dong Y; Du P; Liu P
Int J Pharm; 2020 Oct; 588():119723. PubMed ID: 32755688
[TBL] [Abstract][Full Text] [Related]
36. Fabricating an intelligent cell-like nano-prodrug via hierarchical self-assembly based on the DNA skeleton for suppressing lung metastasis of breast cancer.
Li Y; Yan T; Chang W; Cao C; Deng D
Biomater Sci; 2019 Aug; 7(9):3652-3661. PubMed ID: 31169833
[TBL] [Abstract][Full Text] [Related]
37. Transformable prodrug nanoplatform
Yang W; Yi J; Zhu R; Guo Y; Zhang K; Cao Y; Li X; Zhang J; Zhang Z; Li Y; Chen X
Theranostics; 2023; 13(6):1906-1920. PubMed ID: 37064869
[No Abstract] [Full Text] [Related]
38. In situ Injection of pH- and Temperature-Sensitive Nanomaterials Increases Chemo-Photothermal Efficacy by Alleviating the Tumor Immunosuppressive Microenvironment.
Liu J; Guo L; Rao Y; Zheng W; Gao D; Zhang J; Luo L; Kuang X; Sukumar S; Tu Y; Chen C; Sun S
Int J Nanomedicine; 2022; 17():2661-2678. PubMed ID: 35733417
[TBL] [Abstract][Full Text] [Related]
39. Dual-Loaded Liposomes Tagged with Hyaluronic Acid Have Synergistic Effects in Triple-Negative Breast Cancer.
Dong S; Bi Y; Sun X; Zhao Y; Sun R; Hao F; Sun Y; Wang Y; Li X; Deng W; Liu X; Ha J; Teng L; Gong P; Xie J; Kim BYS; Yang Z; Jiang W; Teng L
Small; 2022 Apr; 18(16):e2107690. PubMed ID: 35277914
[TBL] [Abstract][Full Text] [Related]
40. Dual-prodrug cascade activation for chemo/chemodynamic mutually beneficial combination cancer therapy.
Zhang X; Guo H; Zhang X; Shi X; Yu P; Jia S; Cao C; Wang S; Chang J
Biomater Sci; 2023 Jan; 11(3):1066-1074. PubMed ID: 36562486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
